Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers.
Nature Communications
Shah, Jennifer B JB; Pueschl, Dana D; Wubbenhorst, Bradley B; Fan, Mengyao M; Pluta, John J; D'Andrea, Kurt K; Hubert, Anna P AP; Shilan, Jake S JS; Zhou, Wenting W; Kraya, Adam A AA; Llop Guevara, Alba A; Ruan, Catherine C; Serra, Violeta V; Balmaña, Judith J; Feldman, Michael M; Morin, Pat J PJ; Nayak, Anupma A; Maxwell, Kara N KN; Domchek, Susan M SM; Nathanson, Katherine L KL
Genetically determining individualized clinical reference ranges for the biomarker tryptase can limit unnecessary procedures and unmask myeloid neoplasms.
Blood Advances
Chovanec, Jack J; Tunc, Ilker I; Hughes, Jason J; Halstead, Joseph J; Mateja, Allyson A; Liu, Yihui Y; O'Connell, Michael M; Kim, Jiwon J; Park, Young Hwan YH; Wang, Qinlu Q; Le, Quang Trong QT; Pirooznia, Mehdi M; Trivedi, Neil N; Bai, Yun Y; Yin, Yuzhi Y; Hsu, Amy P AP; McElwee, Joshua J JJ; Lassiter, Sheryce S; Nelson, Celeste C; Bandoh, Judy J; DiMaggio, Thomas T; Selb, Julij J; Rijavec, Matija M; Carter, Melody C MC; Komarow, Hirsh H; Sabato, Vito V; Steinberg, Joshua A JA; Hafer, Kurt M KM; Feuille, Elizabeth E; Hourigan, Christopher S CS; Lack, Justin J; Khoury, Paneez P; Maric, Irina I; Zanotti, Roberta R; Bonadonna, Patrizia P; Schwartz, Lawrence B LB; Milner, Joshua D JD; Glover, Sarah S; Ebo, Didier G DG; Korosec, Peter P; Caughey, George G; Brittain, Erica E; Busby, Ben B; Metcalfe, Dean D DD; Lyons, Jonathan J JJ
Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer.
Nature Communications
Roper, Nitin N; Velez, Moises J MJ; Chiappori, Alberto A; Kim, Yoo Sun YS; Wei, Jun S JS; Sindiri, Sivasish S; Takahashi, Nobuyuki N; Mulford, Deborah D; Kumar, Suresh S; Ylaya, Kris K; Trindade, Christopher C; Manukyan, Irena I; Brown, Anna-Leigh AL; Trepel, Jane B JB; Lee, Jung-Min JM; Hewitt, Stephen S; Khan, Javed J; Thomas, Anish A
Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.
Nature Communications
Ando, Mizuo M; Saito, Yuki Y; Xu, Guorong G; Bui, Nam Q NQ; Medetgul-Ernar, Kate K; Pu, Minya M; Fisch, Kathleen K; Ren, Shuling S; Sakai, Akihiro A; Fukusumi, Takahito T; Liu, Chao C; Haft, Sunny S; Pang, John J; Mark, Adam A; Gaykalova, Daria A DA; Guo, Theresa T; Favorov, Alexander V AV; Yegnasubramanian, Srinivasan S; Fertig, Elana J EJ; Ha, Patrick P; Tamayo, Pablo P; Yamasoba, Tatsuya T; Ideker, Trey T; Messer, Karen K; Califano, Joseph A JA
Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum.
Oncotarget
Greenawalt, Danielle M DM; Liang, Winnie S WS; Saif, Sakina S; Johnson, Justin J; Todorov, Petar P; Dulak, Austin A; Enriquez, Daniel D; Halperin, Rebecca R; Ahmed, Ambar A; Saveliev, Vladislav V; Carpten, John J; Craig, David D; Barrett, J Carl JC; Dougherty, Brian B; Zinda, Michael M; Fawell, Stephen S; Dry, Jonathan R JR; Byth, Kate K
Publication Date: 2017-11-21
Variant appearance in text: MLL3: 2459C>T; rs200598064
Whole-exome analysis in osteosarcoma to identify a personalized therapy.
Oncotarget
Chiappetta, Caterina C; Mancini, Massimiliano M; Lessi, Francesca F; Aretini, Paolo P; De Gregorio, Veronica V; Puggioni, Chiara C; Carletti, Raffaella R; Petrozza, Vincenzo V; Civita, Prospero P; Franceschi, Sara S; Naccarato, Antonio G AG; Rocca, Carlo Della CD; Mazzanti, Chiara M CM; Di Cristofano, Claudio C
Publication Date: 2017-10-06
Variant appearance in text: KMT2C: 2459C>T; Thr820Ile
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Oncotarget
Raaijmakers, Marieke I G MI; Widmer, Daniel S DS; Narechania, Apurva A; Eichhoff, Ossia O; Freiberger, Sandra N SN; Wenzina, Judith J; Cheng, Phil F PF; Mihic-Probst, Daniela D; Desalle, Rob R; Dummer, Reinhard R; Levesque, Mitchell P MP